Online Program Home
My Program

CC = Colorado Convention Center   H = Hyatt Regency Denver at Colorado Convention Center
* = applied session       ! = JSM meeting theme

Activity Details

9 * ! Sun, 7/28/2019, 2:00 PM - 3:50 PM CC-111
Impact of Using Surrogate Endpoints on Drug Development — Invited Papers
WNAR, International Chinese Statistical Association, Biopharmaceutical Section
Organizer(s): Ying Lu, Stanford University
Chair(s): Ying Zhang, University of Nebraska Medical Center
2:05 PM Havrda and Charvat Entropy-Based Measures to Assess Longitudinal Surrogate Endpoints in Clinical Trials
MarĂ­a del Carmen Pardo , Complutense University; Ying Lu, Stanford University; Hua Jin, South China Normal University; Qian Zhao, Guangzhou Medical University
2:25 PM Statistical Considerations for Biomarker-Based Surrogate Endpoints
Marc Buyse, IDDI Inc.
2:45 PM An Information-Theoretic Approach for the Evaluation of Surrogate Endpoints Based on Causal Inference

Ariel Alonso Abad, KUleuven
3:05 PM Model Free Approach to Quantifying the Proportion of Treatment Effect Explained by a Surrogate Marker

Lu Tian, Stanford University School of Medicine; Tianxi Cai, Harvard University ; Xuan Wang, Harvard University; Layla Parast, RAND
3:25 PM Discussant: Ying Lu, Stanford University
3:45 PM Floor Discussion